Jason Baumgartner of BEKhealth Corporation Talks About The Current State of Research Operations in a COVID World with TrialSite

Jason CEO of BEKhealth Corporation talks with TrialSite about the current state of research operations in a COVID world. How COVID has impacted researcher capacity. How technology is improving patient pre-screening and enrollment. How sites can implement new technologies to alleviate manual processes and see more patients.

Listen to the podcast here